In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Inverness Medical nets $79.3mm with private financing

Executive Summary

Inverness Medical Innovations has netted $79.3mm with the private placement of 3.4mm common shares priced at $24.41 each (a 9% discount to the market average) to 14 accredited institutional investors. The company sells OTC products including ovulation and pregnancy tests, nutritional supplements, and drug monitors.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Medical Devices
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Private Investment in Public Equity

Related Companies

Advertisement
UsernamePublicRestriction

Register